Skip to main content

Table 6 Dossier unique study evidence by disease category (total = 123)

From: A study of the value of requesting information from drug manufacturers for systematic reviews; 9 years of experience from the drug effectiveness review project

Clinical category Number of reports Total studies (mean/review) Study quality
Good Fair Poor
Cardiovascular 3 0 (0)
Dermatology 1 6 (6) 6 (100%)
Endocrinology 3 12 (4) 10 (10.4%) 2 (17%)
Gastrointestinal 2 22 (11) 1 18 (19%) 3
Hepatitis 2 8 (4) 3 (38%) 4 (50%) 1 (13%)
Neurology/pain 5 11 (2) 2 (18%) 7 (64%) 2 (18%)
Psychiatry 6 46 (8) 2 (4.3%) 39 (85%) 5 (11%)
Respiratory 3 18 (9) 1 (5.6%) 12 (67%) 5 (27.8%)